- Home
- THR vs REPL Comparison
THR vs REPL Comparison
Compare THR & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THR
- REPL
- Stock Information
- Founded
- THR 1954
- REPL 2015
- Country
- THR United States
- REPL United States
- Employees
- THR N/A
- REPL N/A
- Industry
- THR Industrial Machinery/Components
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- THR Energy
- REPL Health Care
- Exchange
- THR Nasdaq
- REPL Nasdaq
- Market Cap
- THR 960.7M
- REPL 897.3M
- IPO Year
- THR 2011
- REPL 2018
- Fundamental
- Price
- THR $28.69
- REPL $12.49
- Analyst Decision
- THR Strong Buy
- REPL Strong Buy
- Analyst Count
- THR 1
- REPL 6
- Target Price
- THR $38.00
- REPL $17.50
- AVG Volume (30 Days)
- THR 209.4K
- REPL 1.3M
- Earning Date
- THR 01-30-2025
- REPL 02-06-2025
- Dividend Yield
- THR N/A
- REPL N/A
- EPS Growth
- THR 4.78
- REPL N/A
- EPS
- THR 1.29
- REPL N/A
- Revenue
- THR $493,855,000.00
- REPL N/A
- Revenue This Year
- THR $2.25
- REPL N/A
- Revenue Next Year
- THR $8.83
- REPL $300.41
- P/E Ratio
- THR $22.26
- REPL N/A
- Revenue Growth
- THR 3.94
- REPL N/A
- 52 Week Low
- THR $23.76
- REPL $4.92
- 52 Week High
- THR $35.93
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- THR 32.13
- REPL 50.53
- Support Level
- THR $30.95
- REPL $11.19
- Resistance Level
- THR $33.25
- REPL $12.79
- Average True Range (ATR)
- THR 1.03
- REPL 0.70
- MACD
- THR -0.49
- REPL -0.14
- Stochastic Oscillator
- THR 4.20
- REPL 52.21
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.